Big Pharma comparative analysis ---> a great time for them now ?
Timestamp (black vertical line) : Mar 1 2020
---> Lockdowns worldwide due to Covid-19
- - - - - - - - - - - - - - - - - - - - - - - - - - -
GlaxoSmithKline plc ( GSK )
LSE:GSK
GlaxoSmithKline plc ( GSK ) is a British multinational pharmaceutical company headquartered in Brentford, England.
Price decrease of 9.50%
- - - - - - - - - - - - - - - - - - - - - - - - - - -
Sorrento Therapeutics Inc.
NASDAQ:SRNE
Sorrento Therapeutics , Inc. is a biopharmaceutical company. It is based San Diego (Calif.), USA
Price increase of 230%
- - - - - - - - - - - - - - - - - - - - - - - - - - -
As an ever greater number of companies seek to provide vaccines and enter the lucrative race of who will provide what
and who will be awarded plush government contracts, we can see that not all Big Pharma stocks are shining, pricewise.
Time will tell but if hindsight can teach us something, it is that whoever invested in this rather obscure and not well known company
called 'Sorrento Therapeutics", the investment would have been more rewarding than a comparable investment into GlaxoSmithKline plc .
Words of wisdom: if you have extra cash lying around, do a careful and thorough analysis first.
That is true, at all time, and even more so now, in this Covid-branded and forever altered world.
Francois Normandeau
Institutional Research Director for ADX-BRIEFING
P.S.
Live Stream on TradingView on Friday, January 1, 2021, at 6 am NY time, open to all.
See you there.
---> Lockdowns worldwide due to Covid-19
- - - - - - - - - - - - - - - - - - - - - - - - - - -
GlaxoSmithKline plc ( GSK )
LSE:GSK
GlaxoSmithKline plc ( GSK ) is a British multinational pharmaceutical company headquartered in Brentford, England.
Price decrease of 9.50%
- - - - - - - - - - - - - - - - - - - - - - - - - - -
Sorrento Therapeutics Inc.
NASDAQ:SRNE
Sorrento Therapeutics , Inc. is a biopharmaceutical company. It is based San Diego (Calif.), USA
Price increase of 230%
- - - - - - - - - - - - - - - - - - - - - - - - - - -
As an ever greater number of companies seek to provide vaccines and enter the lucrative race of who will provide what
and who will be awarded plush government contracts, we can see that not all Big Pharma stocks are shining, pricewise.
Time will tell but if hindsight can teach us something, it is that whoever invested in this rather obscure and not well known company
called 'Sorrento Therapeutics", the investment would have been more rewarding than a comparable investment into GlaxoSmithKline plc .
Words of wisdom: if you have extra cash lying around, do a careful and thorough analysis first.
That is true, at all time, and even more so now, in this Covid-branded and forever altered world.
Francois Normandeau
Institutional Research Director for ADX-BRIEFING
P.S.
Live Stream on TradingView on Friday, January 1, 2021, at 6 am NY time, open to all.
See you there.
